Angiotensin‐converting enzyme inhibitors vs placebo
Electrolyte levels · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
- Angiotensin‐converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 22 participantsVery low